Latest filing published 07 Oct 2025 for Prelude Therapeutics Inc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Jane Huang span 2 companies, the busiest being BeOne Medicines Ltd. and Prelude Therapeutics Inc. We count 24 filings; the first trade dates from 29 April 2021 and the latest from 4 October 2025.
No open-market purchase appears, only 3 sales worth €1.6M. The rest of the record consists of 4 share grants and 17 option exercises.
The newest entry dates from 7 October 2025: an option exercise, in Prelude Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations